Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Operating Expenses: 2024-2025

Historic Operating Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $23.5 million.

  • Pyxis Oncology's Operating Expenses fell 1.23% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year change of. This contributed to the annual value of $105.6 million for FY2024, which is 28.48% up from last year.
  • Latest data reveals that Pyxis Oncology reported Operating Expenses of $23.5 million as of Q3 2025, which was up 3.95% from $22.6 million recorded in Q2 2025.
  • Pyxis Oncology's Operating Expenses' 5-year high stood at $40.1 million during Q4 2024, with a 5-year trough of $20.0 million in Q2 2024.
  • Its 2-year average for Operating Expenses is $24.9 million, with a median of $22.9 million in 2025.
  • Data for Pyxis Oncology's Operating Expenses shows a peak YoY increase of 12.67% (in 2025) and a maximum YoY decrease of 1.23% (in 2025) over the last 5 years.
  • Pyxis Oncology's Operating Expenses (Quarterly) stood at $40.1 million in 2024, then declined by 1.23% to $23.5 million in 2025.
  • Its Operating Expenses was $23.5 million in Q3 2025, compared to $22.6 million in Q2 2025 and $22.9 million in Q1 2025.